Loading clinical trials...
Loading clinical trials...
Context: Obesity, defined as excessive body fat, can lead to disability and loss of autonomy. If there is concomitant quantitative and qualitative muscle loss, sarcopenic obesity (SO) is suspected in ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Clermont-Ferrand
NCT06951893 · Obesity, Morbid, Obesity and Overweight, and more
NCT07311850 · Obesity and Overweight
NCT07049861 · Weight Management, Obesity Prevention, and more
NCT06623669 · Chronic Pain, Osteoarthritis, and more
NCT06768827 · Obesity and Overweight, Insulin Resistance, and more
CHU Clermont-Ferrand
Clermont-Ferrand
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions